Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy

NCT03111121 is registered in ClinicalTrials.gov with West Virginia University as lead sponsor.

NCT NCT03111121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03111121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Sugammadex for Reversal of Paralysis in Microlaryngoscopy
Lead sponsor
West Virginia University
Phase
Phase 4
Overall status
Completed
Start date
May 4, 2017
Completion date
May 30, 2019
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microlaryngoscopy, rigid bronchoscopy